ArticlePhysiological reports2019

SGLT2 inhibitor ipragliflozin alone and combined with pioglitazone prevents progression of nonalcoholic steatohepatitis in a type 2 diabetes rodent model.

Atsuo Tahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.